Meet the Management Team

Dr Michalis Papadakis

Dr Michalis Papadakis

CEO & Co-Founder

Dr Michalis Papadakis is the CEO and co-founder of Brainomix. He leads the management team, commercial strategy, fund raising, and corporate partnerships. He has grown the company from the ground up, building the company’s global presence and has raised over £15 million of private investment and public funding. When he founded Brainomix he was the Scientific Director of the preclinical stroke lab at the University of Oxford. He has a BSc Honours in Biochemistry from Imperial College London and a PhD in neurosciences from UCL School of Pharmacy. He has been an invited speaker at international scientific and innovation conferences.

Eric Greveson

Eric Greveson

Chief Technology Officer

Eric is the CTO of Brainomix. He received his 1st class M.Eng.in Engineering from Cambridge University, and has worked on a wide variety of computer vision projects. These include video processing and 3D graphics algorithms, real-time data capture software, parallel grid computing systems, and data visualization. He has extensive experience in software engineering, design, and programming with languages such as C++ and Python. At Brainomix, Eric works with the clinical and business teams to deliver the company's state-of-the-art medical imaging software.

George Harston

George Harston

Chief Medical & Innovation Officer

Dr George Harston is Chief Medical and Innovation Officer at Brainomix. He is also a Consultant Physician in Stroke and General Medicine at Oxford University Hospitals NHS Foundation Trust. He is responsible for coordinating clinical research collaborations and leading innovation at Brainomix. George received his medical degree from the University of Cambridge in 2006. In 2015 George was awarded a DPhil (PhD) from the University of Oxford, following which he continued his research and clinical activity as Clinical Lecturer in the Acute Vascular Imaging Centre. His research interests centre around the development and analysis of CT and MRI to better understand the pathophysiology of acute stroke and global brain injury.

Jeff Wyrtzen

Jeff Wyrtzen

Chief Marketing & Business Development Officer

Jeff is the Head of Marketing & Business Development for Brainomix. He received a BA in Modern History from Brown University in Rhode Island, USA, and also studied at Oxford University as a Visiting Scholar. Jeff is responsible for Brainomix’s marketing function, launching key strategic initiatives, and identifying and driving business development opportunities across all channels. Prior to joining Brainomix in early 2019, he worked at Medtronic for 14 years serving in European and Global Marketing roles.

Gwilym Owen

Gwilym Owen

Head of Quality Assurance and Regulatory Affairs

Gwilym is the Head of Quality Assurance and Regulatory Affairs for Brainomix. He has BScEcon Honours degree in International Politics and a Master’s degree in International Relations from Aberystwyth University. He is responsible for regulatory compliance and quality management and leads international regulatory clearance activities. Gwilym has 15 years of extensive experience in quality assurance and regulatory affairs for medical imaging software devices and has worked for large multinational companies as well as start-ups and SMEs.

Riaz Rahman

Riaz Rahman

VP Healthcare Global

Riaz is Vice President Healthcare Global at Brainomix. He has a BSc Honours degree in Human Genetics from King’s College London and a Masters degree in Human Molecular Genetics from Imperial College London. He is responsible for the company’s revenue, direct sales operations and the management of distributor, agent and channel strategies globally. He leads the development of national and international sales strategies and manages relationships with clinicians and key opinion leaders in each country after market entry. He has held a number of senior management and commercial positions in Pharmaceuticals, Management Information, Health Consultancy and Technology with over 17 years’ experience of working with private and public healthcare.

Our Partners